📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol (2013)

First Author: Haynes R

Attributed to: CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/2047-1440-2-7

PubMed Identifier: 23641902

Publication URI: http://europepmc.org/abstract/MED/23641902

Type: Journal Article/Review

Parent Publication: Transplantation Research

Issue: 1

ISSN: 2047-1440